Resmed (RMD) Asset Writedowns and Impairment (2009 - 2020)

Resmed (RMD) has 10 years of Asset Writedowns and Impairment data on file, last reported at $9.1 million in Q1 2020.

• For the quarter ending Q1 2020, Asset Writedowns and Impairment rose 55.77% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2020 stood at $20.7 million (up 23.55% YoY), and the FY2019 full-year result was $15.0 million, up 29.45% from the prior year.
• Asset Writedowns and Impairment for Q1 2020 stood at $9.1 million, up from $2.8 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $9.1 million in Q1 2020 and bottomed at -$2.1 million in Q2 2016.
• The 5-year median for Asset Writedowns and Impairment is $1.7 million (2018), against an average of $2.9 million.
• The widest annual swing landed in 2017, when Asset Writedowns and Impairment slumped 81.5%; it then soared 483.25% in 2018.
• A 5-year view of Asset Writedowns and Impairment shows it stood at -$2.1 million in 2016, then surged by 162.57% to $1.3 million in 2017, then dropped by 3.41% to $1.2 million in 2018, then surged by 126.68% to $2.8 million in 2019, then surged by 221.67% to $9.1 million in 2020.
• The last three Asset Writedowns and Impairment figures came in at $9.1 million (Q1 2020), $2.8 million (Q4 2019), and $2.6 million (Q3 2019), per Business Quant data.

Peer Comparison